Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression

Endocrine-Related Cancer

Volumn 14, Issue 2, 2007, Pages 189-206

  Vona Davis, Linda ^a   Rose, David P ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANASTROZOLE; ESTROGEN RECEPTOR; FULVESTRANT; LEPTIN; SCATTER FACTOR; TAMOXIFEN;

AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL INVASION; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; ENDOCRINE FUNCTION; HORMONE ACTION; HUMAN; NONHUMAN; PARACRINE SIGNALING; REVIEW; RISK FACTOR; TUMOR CELL;

ADIPONECTIN; AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LEPTIN; PARACRINE COMMUNICATION; RISK;

EID: 34547741589     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-06-0068     Document Type: Review

References (139)

1. Abramovitch R, Neeman M, Reich R, Stein I, Keshet E, Abraham J, Solomon A & Marikovsky M 1998 Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Letters 425 441-447.
2. Artwohl M, Roden M, Holsenbein T, Freudenthaler A, Waldhausl W & Baumgartner-Parzer SM 2002 Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. International Journal of Obesity and Related Metabolic Disorders 26 577-580.
3. Bajoria R, Sooranna SR, Ward BS & Chatterjee R 2002 Prospective function of placental leptin at maternal-fetal interface. Placenta 23 103-115.
4. Barb D, Pazaitou-Panayiotou K & Mantzoros CS 2006 Adiponectin: a link between obesity and cancer. Expert Opinions in Investigative Drugs 15 917-931.
5. Baumann H, Morella KK, White DW, Dembski M, Bailon PS, Kim H, Lai CF & Tartaglia LA 1996 The full-length receptor has signaling capabilities of interleukin 6-type cytokine receptors. PNAS 93 8374-8378.
6. Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS et al. 2006 Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. American Journal of Physiology, Endocrinology and Metabolism 291 E843-E848.
7. Bellusci S, Moens G, Guadino G, Comoglio P, Nakamura T, Thiery JP & Jouanneau J 1994 Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9 1091-1099.
8. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR & Matthews W 1996 A role for leptin and its cognate receptor in hematopoiesis. Current Biology 6 1170-1180.
9. Bjorbaek C, Uotani S, da Silva B & Flier JS 1997 Divergent signaling capacities of the long and short isoforms of the leptin receptor. Journal of Biological Chemistry 272 32686-32695.
10. Blundell JE, Goodson S & Halford JC 2001 Regulation of appetite: role of leptin in signaling systems for drive and satiety. International Journal of Obesity and Related Metabolic Disorders 25 S29-S34.
11. Boudreau N & Myers C 2003 Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment. Breast Cancer Research 5 140-146.
12. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T & Cao Y 2004 Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. PNAS 101 2476-2481.
13. Brinkmann V, Foroutan H, Sachs M, Weidner KM & Birchmeier W 1995 Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. Journal of Cell Biology 131 1573-1586.
14. Bulun SE, Mahendroo MS & Simpson ER 1994 Aromatase gene expression in adipose tissue: relationship to breast cancer. Journal of Steroid Biochemistry and Molecular Biology 49 319-326.
15. Catalano S, Marsico S, Giordano C, Mauro L, Rizza P, Panno ML & Ando S 2003 Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. Journal of Biological Chemistry 278 28668-28676.
16. Catalano S, Mauro L, Marsico S, Giordano C, Rizza P, Rago V, Montanora D, Maggiolini M, Panno ML & Ando S 2004 Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. Journal of Biological Chemistry 279 19908-19915.
17. Celis JE, Moreira JM, Cabezon T, Gromov P, Friis E, Rank F & Gromova I 2005 Indentification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Molecular and Cellular Proteomics 4 492-522.
18. Cella F, Giordano G & Cordera R 2000 Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. European Journal of Endocrinology 142 174-178.
19. Cento RM, Proto C, Spada RS, Napolitano V, Ciampelli M, Cucinelli F & Lanzone A 1999 Leptin levels in menopause: effect of estrogen replacement therapy. Hormone Research 52 269-273.
20. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF & Yuan SS 2006a Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Letters 237 109-114.
21. Chen C, Chang YC, Liu CL, Chang KJ & Guo IC 2006b Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Research and Treatment 98 121-132.
22. Cleary MP, Phillips FC, Getzin SC, Jacobson TL, Jacobson MK, Christensen TA, Juneja SC, Grande JP & Maihle NJ 2003 Genetically obese MMTV-TGF-α/Lepob Lepob female mice do not develop mammary tumors. Breast Cancer Research and Treatment 77 205-215.
23. Cleary MP, Juneja SC, Phillips FC, Hu X, Grande JP & Maihle NJ 2004 Leptin receptor-deficient MMTV-TGF-α/Lepdb Lepdb female mice do not develop mammary tumors. Experimental Biology and Medicine 229 182-193.
24. Coskun U, Gunel N, Toruner FB, Sancak B, Onuk E, Bayram O, Cengiz O, Yilmaz E, Elbeg S & Ozkan S 2003 Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma 50 41-46.
25. Crichton MB, Nichols JE, Zhao Y, Bulun SE & Simpson ER 1996 Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells and adipose stromal cells. Molecular and Cellular Endocrinology 118 215-220.
26. Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH & Lee AV 2006 Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration. Cancer Research 66 5304-5313.
27. Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I 2007 Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. European Journal of Obstetrics, Gynaecology and Reproductive Biology [in press].
28. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D & Goodwin PJ 1998 Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Research and Treatment 47 111-120.
29. Dieudonne M-N, Machinal-Quelin F, Serazin-Leroy V, Leneveu MC, Pecquery R & Giudicelli Y 2002 Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochemical and Biophysical Research Communications 293 622-628.
30. Dieudonne M-N, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y & Pecquery R 2006 Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochemical and Biophysical Research Communications 345 271-279.
31. Edakuni G, Sasatomi E, Satoh T, Tokunaga O & Miyazaki K 2001 Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathology International 51 172-178.
32. Engels K, Fox SB & Harris AL 1997 Angiogenesis as a biologic and prongnostic indicator in human breast carcinoma. EXS 79 113-156.
33. Fain JN, Madan AK, Hiler ML, Cheema P & Bahouth SW 2004 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 145 2273-2282.
34. Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Kohler C, Fucker K & Julius U 2002 Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetologia 39 105-110.
35. Frankenberry KA, Skinner H, Somasundar P, McFadden DW & Vona-Davis LC 2006 Leptin receptor expression and cell signaling in breast cancer. International Journal of Oncology 28 985-993.
36. Franks PW, Brage S, Luan J, Ekelund U, Rahman M, Farooqi IS, Halsall I, O'Rahilly S & Wareham NJ 2005 Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obesity Research 13 1476-1484.
37. Frater-Schroder M, Risau W, Hallmann R, Gautschi P & Bohlen P 1987 Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. PNAS 84 5277-5281.
38. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB & Flier JS 1995 Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Medicine 1 1311-1314.
39. Fujiuchi Y, Nagakawa O, Murakami K, Fuse H & Saiki 12003 Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncology Reports 10 1001-1006.
40. Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, Chatterjee K, Garkavtsev I & Jain RK 2003 Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circulation Research 93 e88-e97.
41. Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S & Matsuzawa Y 1999 Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Internal Medicine 38 202-206.
42. Garofalo C, Sisci D & Surmacz E 2004 Leptin interferes with the effects of the antiestrogen ICI 182, 780 in MCF-7 breast cancer cells. Clinical Cancer Research 10 6466-6475.
43. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Russo A, Sulkowski & Surmacz E 2006 Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clinical Cancer Research 12 1447-1453.
44. Geisthovel F, Jochmann N, Widjaja A, Horn R & Brabant G 2004 Serum pattern of circulating free leptin, bound leptin, and soluble leptin receptor in the physiological menstrual cycle. Fertility and Sterility 81 398-402.
45. Gilmore AP, Valentin AJ, Wang P, Rangaer AM, Bundred N, O'Hare MJ, Wakeling A, Korsmeyer SJ & Streuli CH 2002 Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. Journal of Biological Chemistry 277 27643-27650.
46. Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T et al. 2006 Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor tye two (VEGF-R2). Journal of Biological Chemistry 281 26320-26328.
47. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B & Hood N 2002 Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. Journal of Clinical Oncology 20 42-51.
48. Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J & Hood N 2005 Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? Journal of Clinical Oncology 23 6037-6042.
49. Groschl M, Wagner R, Dorr HG, Blum W, Rascher W & Dotsch J 2000 Variability of leptin values measured from different sample matrices. Hormone Research 54 26-31.
50. Hakkak R, Holley AW, MacLeod SL, Simpson PM, Fuchs GJ, Jo CH, Kieber-Emmons T & Korourian S 2005 Obesity promotes 7,12-dimethylbenz(a) anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Research 7 R627-R633.
51. Han C, Zhang HT, Du L, Liu X, Jing J, Zhao X, Yang X & Tian B 2005 Serum levels of leptin, insulin, and lipids in relation to breast cancer in China. Endocrine 26 19-24.
52. Harvie M, Hooper L & Howell AH 2003 Central obesity and breast cancer risk: a systemic review. Obesity Reviews 4 157-173.
53. Hausman GJ & Richardson RL 2004 Adipose tissue angiogenesis. Journal of Animal Science 82 925-934.
54. Hayase H, Nomura S, Abe T & Izawa T 2002 Relation between fat distributions and several plasma adipocytokines after exercise training in premenopausal and postmenopausal women. Journal of Physiological Anthropology and Applied Human Science 21 105-113.
55. Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N & Tajima K 2003 Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pacific-Journal of Cancer Prevention 4 239-246.
56. Hu X, Juneja SC, Maihle NJ & Cleary MP 2002 Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. Journal of National Cancer Institute 94 1704-1711.
57. Ishikawa M, Kitayama J & Nagawa H 2004 Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clinical Cancer Research 10 4325-4331.
58. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C & Lisanti MP 2003 Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and protooncogene stabilization. Oncogene 22 6408-6423.
59. Jensen EV & Jordan VC 2003 The estrogen receptor: a model for molecular medicine. Clinical Cancer Research 9 1980-1989.
60. Jin L, Zhang S, Burguera BG, Couce ME, Osamura RY, Kulig E & Lloyd RV 2000 Leptin and leptin receptor expression in rat and mouse pituitary cells. Endocrinology 141 333-339.
61. de Jong PC, Blankenstein MA, van de Ven J, Nortier JW, Blijham GH & Thijssen JH 2001 Importance of local aromatase activity in hormone-dependent breast cancer: a review. Breast 10 91-99.
62. Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon do K & Roh YK 2005 Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Archives of Pharmacological Research 28 1263-1269.
63. Kelesidis I, Kelesidis T & Mantzoros CS 2006 Adiponectin and cancer: a systematic review. British Journal of Cancer 94 1221-1225.
64. Kermorgant S, Aparicio T, Dessirier V, Lewin MJ & Lehy T 2001 Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis 22 1037-1042.
65. Kern PA, Di Gregorio GB, Lu T, Rassouli N & Ranganathan G 2003 Adiponectin ezpression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 1779-1785.
66. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R et al. 2003 Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute 95 1218-1226.
67. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T & Matsuzawa Y 2004 Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research 94 e27-e31.
68. Korner A, Wabitsch M, Seidel B, Fischer-Posovszky P, Berthold A, Stumvoll M, Bluher M, Kratzsch J & Kiess W 2005 Adiponectin expession in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochemical and Biophysical Research Communications 337 540-550.
69. Lammert A, Kiess W, Bottner A, Glasow A & Kratzsch J 2001 Soluble leptin receptor represents the main leptin binding activity in human blood. Biochemistry and Biophysics Research Communications 283 982-988.
70. Laud K, Gourdon I, Pessemesse L, Peyrat JP & Djiane J 2002 Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Molecular and Cellular Endocrinology 188 219-226.
71. Lawlor DA, Smith GD & Ebrahim S 2004 Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes and Control 15 267-275.
72. Ludes-Meyers JH, Liu Y, Munoz-Medellin D, Hilsenbeck SG & Brown PH 2001 AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene 20 2771-2780.
73. MacDougald OA, Hwang CS, Fan H & Lane MD 1995 Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. PNAS 92 9034-9037.
74. Machinal-Quelin F, Dieudonne M-N, Pecquery R, Leneveu MC & Giudicelli Y 2002 Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 18 179-184.
75. Magoffin DA, Weitsman SR, Aagarwal SK & Jakimiuk AJ 1999 Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women. Ginekologia Polska 70 1-7.
76. Manabe Y, Toda S, Miyazaki K & Sugihara H 2003 Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. Journal of Pathology 201 221-228.
77. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G et al. 2004 Adiponectin and breast cancer risk. Journal of Clinical Endocrinology and Metabolism 89 1102-1107.
78. Martin TA, Parr C, Davies G, Watkins G, Lane J, Matsumoto K, Nakamura T, Mansel RE & Jiang WG 2003 Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24 1317-1323.
79. Marttunen MB, Andersson S, Hietanen P, Karonen SL, Koistinen HA, Koivisto VA, Tiitinen A & Ylikorkala O 2000 Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients. Maturitas 35 175-179.
80. Matsumoto K & Nakamura T 2006 Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. International Journal of Cancer 119 477-483.
81. Matsumoto S, Kishida K, Shimomura I, Maeda N, Nagaretani H, Matsuda M, Nishizawa H, Kihara S, Funahashi T, Matsuzawa Y et al. 2002 Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochemical and Biophysical Research Communications 292 781-786.
82. Matsuzawa Y 2005 Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis 6 7-14.
83. McConway MG, Johnson D, Kelly A, Griffin D, Smith J & Wallace AM 2000 Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Annals of Clinical Biochemistry 37 717-723.
84. McGuire WL & Clark GM 1983 Progesterone receptors and human breast cancer. Breast Cancer Research and Treatment 3 157-163.
85. Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun KM & Bulun SE 2001 Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Cancer Research 61 2250-2255.
86. Mick GJ, Wany X & McCormick K 2002 White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 143 948-953.
87. Miller WR, Mullen P, Sourdaine P, Watson C, Dixon JM & Telford J 1997 Regulation of aromatase activity within the breast. Journal of Steroid Biochemistry and Molecular Biology 61 193-202.
88. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y & Noguchi S 2003 Association of serum adiponectin levels with breast cancer risk. Clinical Cancer Research 9 5699-5704.
89. Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I & Noguchi S 2006 High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. International Journal of Cancer 118 1414-1419.
90. Murad A, Nath AK, Cha ST, Demir E, Flores-Riveros J & Sierra-Honigmann MR 2003 Leptin is an autocrine/paracrine regulator of wound healing. FASEB Journal 17 1895-1897.
91. Neels JG, Thinnes T & Loskutoff DJ 2004 Angiogenesis in an in vivo model of adipose tissue development. FASEB Journal 18 983-985.
92. Niranjan B, Buluwela L, Yant J, Perusinghe N, Atherton A, Phippard D, Dale T, Gusterson B & Kamalati T 1995 HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121 2897-2908.
93. O'Brien SN, Welter BH & Price TM 1999 Presence of leptin in breast cell lines and breast tumors. Biochemical and Biophysical Research Communications 259 695-698.
94. Ogier V, Ziegler O, Mejean L, Nicolas JP & Stricker-Krongrad A 2002 Obesity is associated with decreasing levels of the circulating soluble leptin receptor in humans. International Journal of Obesity Research and Metabolic Disorders 26 496-503.
95. Osborne CK, Hobbs K & Trent JM 1987 Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Research and Treatment 9 111-121.
96. Ozet A, Arpaci F, Yilmaz MI, Ayta H, Ozturk B, Komurcu S, Yavuz AA, Tezcan Y & Acikel C 2001 Effects of tamoxifen on the serum leptin level in patients with breast cancer. Japanese Journal of Clinical Oncology 31 424-427.
97. Park HY, Kwon HM, Lim HJ, Hong BK, Kee JY, Park BE, Jang Y, Cho SY & Kim HS 2001 Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Experimental and Molecular Medicine 33 95-102.
98. Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N & Trichopoulos D 2000 Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes and Control 11 383-388.
99. Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E & Trichopoulos D 2002 Leptin and body mass index in relation to endometrial cancer risk. Annals of Nutrition and Metabolism 46 147-151.
100. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G & Trichopoulos D 2003 Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. Journal of Clinical Endocrinology and Metabolism 88 993-997.
101. Purohit A, Newman SP & Reed MJ 2002 The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Research 4 65-69.
102. Purohit A, Singh A, Ghilchik MW, Serlupi-Crescenzi O & Reed MJ 2003 Inhibition of IL-6 + IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts. British Journal of Cancer 88 630-635.
103. Purohit A, Tutill HJ, Day JM, Chander SK, Lawrence HR, Allan GM, Fischer DS, Vicker N, Newman SP, Potter BV et al. 2006 The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer. Molecular and Cellular Endocrinology 248 199-203.
104. Rahimi N, Saulnier R, Nakamura T, Park M & Elliott B 1994 Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA and Cell Biology 13 1189-1197.
105. Ram TG, Kokeny KE, Dilts CA & Ethier SP 1995 Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. Journal of Cell Physiology 163 589-596.
106. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M & Richelsen B 2006 Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity Research 14 28-35.
107. Rehman J, Considine RV, Bovenkerk JE, Li J, Slavens CA, Jones RM & March KL 2003 Obesity is associated with increased levels of circulating hepatocyte growth factor. Journal of the American College of Cardiology 41 1408-1413.
108. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV & March KL 2004 Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109 1292-1298.
109. Riad-Gabriel MG, Jinagouda SD, Sharma A, Boyadjian R & Saad MF 1998 Changes in plasma leptin during the menstrual cycle. European Journal of Endocrinology 139 528-531.
110. Rose DP, Connolly JM & Liu XH 1994 Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Research 54 6557-6562.
111. Rose DP, Gilhooly EM & Nixon DW 2002 Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). International Journal of Oncology 21 1285-1292.
112. Rose DP, Komninou D & Stephenson GD 2004 Obesity, adipocytokines, and insulin resistance in breast cancer. Obesity Reviews 5 153-165.
113. Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL & Polverini P 1993 Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. Symposium of the Society of Experimental Biology 47 227-234.
114. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M & Bado A 2004 Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling. Journal of Biological Chemistry 279 16495-16502.
115. Santen RJ, Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R, Pauley R & Santner S 1998 Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts. Breast Cancer Research and Treatment 49 s93-s99.
116. Sasano H, Suzuki T, Nakata T & Moriya T 2006 New development in intracrinology of breast carcinoma. Breast Cancer 13 129-136.
117. Sauter ER, Garofalo C, Hewett J, Hewett JE, Morelli C & Surmacz E 2004 Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. Hormone and Metabolic Research 36 336-340.
118. Sheen-Chen SM, Liu YW, Eng HL & Chou FF 2005 Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiology, Biomarkers and Prevention 14 715-717.
119. Shida D, Kitayama J, Mori K, Watanabe T & Nagawa H 2005 Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells. Cancer Research 65 9159-9163.
120. Simons PJ, van den Pangaart PS, van Roomen CP, Aerts JM & Boon L 2005 Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha and interleukin-1 beta-treated human predipocytes are potent leptin producers. Cytokine 32 94-103.
121. Singh A, Purohit A, Duncan LJ, Mokbel K, Ghilchik MW & Reed MJ 1997 Control of aromatase activity in breast tumours: the role of the immune system. Journal of Steroid Biochemistry and Molecular Biology 61 185-192.
122. Somasundar P, Yu AK, Vona-Davis L & McFadden DW 2003 Differential effects of leptin on cancer in vitro. Journal of Surgical Research 113 50-55.
123. Stattin P, Soderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R & Olsson T 2004 Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Research and Treatment 86 191-196.
124. Stephenson GD & Rose DP 2003 Breast cancer and obesity: an update. Nutrition and Cancer 45 1-16.
125. Stull MA, Richert MM, Loladze AV & Wood TL 2002 Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. Endocrinology 143 1872-1879.
126. Suganami T, Nishida J & Ogawa Y 2005 A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arteriosclerosis Thrombosis and Vascular Biology 25 2062-2068.
127. Suzuki T, Miki Y, Nakamura Y, Moriya T, I to K, Ohuchi N & Sasano H 2005 Sex steroid-producing enzymes in human breast cancer. Endocrine-Related Cancer 12 701-720.
128. Tanaka M, Nakaya S, Kumai T, Watanabe M, Tateishi T, Shimizu H & Kobayashi S 2001 Effects of estrogen on serum leptin levels and leptin mRNA expression in adipose tissue in rats. Hormone Research 56 98-104.
129. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y & Tominaga T 1995 Serum concentrations of hepatocyte growth factor in breast cancer patients. Clinical Cancer Research 1 1031-1034.
130. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, Benedetto C & Mussa A 2000 Leptin expression in colorectal and breast cancer patients. International Journal of Molecular Medicine 5 421-426.
131. Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H & Tominaga T 1998 Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clinical Cancer Research 4 659-664.
132. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P & Pasternack BS 1995 A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Journal of the National Cancer Institute 87 190-197.
133. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R & Isner JM 1998 Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97 381-390.
134. Wang B, Jenkins JR & Trayhurn P 2005 Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. American Journal of Physiology. Endocrinology and Metabolism 288 E731-E740.
135. Weisburg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrante AW, Jr 2003 Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112 1796-1808.
136. Woo HY, Park H, Ki CS, Park YL & Bae WG 2006 Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Letters 237 137-142.
137. Yamashita T, Murakami T, Otani S, Kuwajima M & Shima K 1998 Leptin receptor signal transduction: OBRa and OBRb of fa type. Biochemical and Biophysical Research Communications 246 752-759.
138. Zhao Y, Nichols JE, Valdez R, Mendelson CR & Simpson ER 1996 Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Molecular Endocrinology 10 1350-1357.
139. Zhao T, Hou M, Xia M, Wang Q, Zhu H, Xiao Y, Tang Z, Ma J & Ling W 2005 Globular adiponectin decreases leptin-induced tumor necrosis factor-alpha expression by murine macrophages: Involvement of cAMP-PKA and MAPK pathways. Cellular Immunology 238 19-30.